Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Keratosis, Actinic 22Cholangiocarcinoma 8Carcinoma, Basal Cell 8Carcinoma, Non-Small-Cell Lung 7Squamous Cell Carcinoma of Head and Neck 6Skin Neoplasms 4Bile Duct Neoplasms 4Pancreatic Neoplasms 3Mesothelioma, Malignant 3Lung Neoplasms 3Liver Neoplasms 3Leukoplakia, Oral 3Colorectal Neoplasms 3Warts 2Tongue Neoplasms 2Prostatic Neoplasms 2Pleural Diseases 2Neoplasms 2Neoplasm Metastasis 2Mycosis Fungoides 2Glioblastoma 2Esophageal Neoplasms 2Carcinoma, Squamous Cell 2Bowen's Disease 2Basal Cell Nevus Syndrome 2Barrett Esophagus 2Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1

Interventions

mirdametinib 2tipifarnib 1talimogene laherparepvec 1peginterferon alfa-2b 1nilotinib 1binimetinib 1antineoplaston AS 2-1 1antineoplaston A10 1Vincristine 1Temozolomide 1Talaporfin 1Sirolimus 1Restraint, Physical 1Ranibizumab 1Radiosurgery 1Photochemotherapy 1Neurofibromin 1 1Mn-PyC3A 1Imatinib Mesylate 1Everolimus 1Elasticity Imaging Techniques 1Deoxycholic Acid 1Cryotherapy 1Celecoxib 1Aminolevulinic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurofibroma × Photochemotherapy × Clear all
NCT02728388 2025-05-08

Photodynamic Therapy for Benign Dermal Neurofibromas- Phase II

Medical College of Wisconsin

Phase 2 Recruiting
30 enrolled
CNS

Neurofibroma, Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡